- Home
- SMFG vs BMY Comparison
SMFG vs BMY Comparison
Compare SMFG & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SMFG | BMY |
|---|---|---|
| Founded | 2002 | 1887 |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 133.3B | 114.0B |
| IPO Year | 1949 | N/A |
Fundamental Metrics
Financial Performance| Metric | SMFG | BMY |
|---|---|---|
| Price | $23.75 | $60.54 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 14 |
| Target Price | N/A | ★ $59.93 |
| AVG Volume (30 Days) | 2.2M | ★ 13.5M |
| Earning Date | 01-30-2026 | 02-05-2026 |
| Dividend Yield | 1.84% | ★ 4.15% |
| EPS Growth | N/A | ★ N/A |
| EPS | 1.22 | ★ 3.46 |
| Revenue | $23,646,126,752.00 | ★ $48,194,000,000.00 |
| Revenue This Year | $38.96 | N/A |
| Revenue Next Year | $4.37 | N/A |
| P/E Ratio | $32.20 | ★ $17.55 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $11.83 | $42.52 |
| 52 Week High | $24.34 | $63.33 |
Technical Indicators
Market Signals| Indicator | SMFG | BMY |
|---|---|---|
| Relative Strength Index (RSI) | 77.45 | 65.95 |
| Support Level | $21.29 | $59.25 |
| Resistance Level | $24.34 | $62.05 |
| Average True Range (ATR) | 0.40 | 1.38 |
| MACD | 0.19 | 0.30 |
| Stochastic Oscillator | 82.73 | 77.81 |
Price Performance
Historical ComparisonAbout SMFG Sumitomo Mitsui Financial Group Inc Unsponsored (Japan)
Sumitomo Mitsui Financial Group is roughly tied with Mizuho Financial Group for the status of Japan's second-largest bank after Mitsubishi UFJ Financial Group. As of March 2025, its market share of domestic loans was 7.3%, compared with 8.4% for MUFG. It has a larger consumer finance business than the other two megabanks, owning 100% of the Promise business and SMBC Card. It also controls one of Japan's largest leasing companies and SMBC Aviation Capital, one of the top five aircraft lessors globally. In securities, its SMBC Nikko unit is Japan's third-largest retail broker, although SMFG has lagged somewhat in institutional securities business and asset management.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.